Detection of Merkel Cell Polyomavirus in Epidermodysplasia-Verruciformis-Associated Skin Neoplasms

Background: Epidermodysplasia verruciformis (EV) is a rare genodermatosis that is characterized by susceptibility to infection with specific human papillomavirus (HPV) genotypes. Among polyomaviruses, the novel Merkel cell polyomavirus (MCPyV) has been found in different epithelial skin neoplasias. Objective: To examine whether EV is associated with cutaneous MCPyV infection. Methods: We used MCPyV-specific PCR to study skin neoplasms of 6 congenital EV patients and of 1 patient with acquired EV. Results: In all congenital EV patients, MCPyV DNA was found in carcinomas in situ, in invasive squamous cell carcinomas and in common warts. In 4 of these patients, the MCPyV-positive skin lesions were from different anatomic locations. In addition, 1 immunosuppressed patient suffering from acquired EV harbored MCPyV DNA in 2 common warts. In contrast, 7 normal skin samples tested negative for MCPyV DNA. Only 2 out of 24 carcinomas in situ (8.3%) and 2 out of 30 common warts (6.7%) from immunocompetent individuals were positive for MCPyV DNA. Conclusions: The strong association of EV-associated skin neoplasms with MCPyV suggests a unique susceptibility of EV patients to infections with MCPyV. Both MCPyV and EV-HPV may act as synergistic oncogenic cofactors in the development of EV-associated skin neoplasms.

[1]  J. Q. Rosso,et al.  Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases , 2011 .

[2]  K. Mertz,et al.  Merkel cell polyomavirus is present in common warts and carcinoma in situ of the skin. , 2010, Human pathology.

[3]  S. Tyring,et al.  Merkel cell polyomavirus in Merkel cell carcinoma from a Brazilian epidermodysplasia verruciformis patient. , 2010, Journal of the American Academy of Dermatology.

[4]  K. Mertz,et al.  Inflammatory monocytes are a reservoir for Merkel cell polyomavirus. , 2010, The Journal of investigative dermatology.

[5]  B. Guillot,et al.  Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases , 2010, The British journal of dermatology.

[6]  M. Flaig,et al.  Prevalence of MCPyV in Merkel cell carcinoma and non‐MCC tumors , 2010, Journal of cutaneous pathology.

[7]  S. Swerdlow,et al.  Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors , 2009, International journal of cancer.

[8]  J. Becker,et al.  Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays , 2009, International journal of cancer.

[9]  Y. Jacob,et al.  The EVER Proteins as a Natural Barrier against Papillomaviruses: a New Insight into the Pathogenesis of Human Papillomavirus Infections , 2009, Microbiology and Molecular Biology Reviews.

[10]  Jérôme Couturier,et al.  Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis , 2009, The Journal of pathology.

[11]  R. Garcea,et al.  Seroepidemiology of Human Polyomaviruses , 2009, PLoS pathogens.

[12]  S. Tyring,et al.  Acquired epidermodysplasia verruciformis. , 2009, Journal of the American Academy of Dermatology.

[13]  B. Thiers,et al.  Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2009 .

[14]  K. Ridd,et al.  The presence of polyomavirus in non-melanoma skin cancer in organ transplant recipients is rare. , 2009, The Journal of investigative dermatology.

[15]  Yuan Chang,et al.  T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus , 2008, Proceedings of the National Academy of Sciences.

[16]  G. Giraud,et al.  DNA from BK Virus and JC Virus and from KI, WU, and MC Polyomaviruses as Well as from Simian Virus 40 Is Not Detected in Non-UV-Light-Associated Primary Malignant Melanomas of Mucous Membranes , 2008, Journal of Clinical Microbiology.

[17]  N. Kiviat,et al.  Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. , 2008, The Journal of investigative dermatology.

[18]  A. Gewirtzman,et al.  Epidermodysplasia verruciformis and human papilloma virus , 2008, Current opinion in infectious diseases.

[19]  K. Shah,et al.  A Skin Cancer Virus? , 2008, Science.

[20]  Y. Jacob,et al.  Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses , 2007, The Journal of experimental medicine.

[21]  M. Gönül,et al.  Clinical aspects of epidermodysplasia verruciformis and review of the literature , 2007, International journal of dermatology.

[22]  G. Orth.  Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. , 2006, Seminars in immunology.

[23]  S. Tyring,et al.  Skin cancer in epidermodysplasia verruciformis patients from Brazil , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[24]  G. Orth.  Human papillomaviruses associated with epidermodysplasia verruciformis in non-melanoma skin cancers: guilty or innocent? , 2005, The Journal of investigative dermatology.

[25]  Xuejun Zhang,et al.  Two frameshift mutations in the RNA-specific adenosine deaminase gene associated with dyschromatosis symmetrica hereditaria. , 2005, Archives of dermatology.

[26]  F. Lewandowsky,et al.  Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis) , 1922, Archiv für Dermatologie und Syphilis.

[27]  S. Jabłońska,et al.  Possible involvement of epidermodysplasia verruciformis human papillomaviruses in the immunopathogenesis of psoriasis: a proposed hypothesis , 2003, Experimental dermatology.

[28]  D. Cohen,et al.  Epidermodysplasia verruciformis. (Case Report) , 2003 .

[29]  N. Ramoz,et al.  Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis , 2002, Nature Genetics.

[30]  S. Jabłońska,et al.  Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? , 2002, Archives of dermatology.

[31]  P. Häusermann,et al.  Das Lewandowsky-Lutz-Syndrom: Die Erstbeschreibung und drei weitere Basler Fälle der Epidermodysplasia verruciformis , 2002 .

[32]  C. Proby,et al.  Human papillomaviruses and non-melanoma skin cancer , 2002, Current opinion in infectious diseases.

[33]  A. Degener,et al.  Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre. , 2000, The Journal of general virology.

[34]  N. Ramoz,et al.  Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. , 2000, The Journal of investigative dermatology.

[35]  E. de Villiers,et al.  Degenerate and Nested PCR: a Highly Sensitive and Specific Method for Detection of Human Papillomavirus Infection in Cutaneous Warts , 1999, Journal of Clinical Microbiology.

[36]  P. Fuchs,et al.  High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. , 1999, The Journal of investigative dermatology.

[37]  D. Relman,et al.  Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates , 1996, Clinical microbiology reviews.

[38]  A. Bowcock,et al.  Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. , 1994, Science.

[39]  S. Jablonska,et al.  Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. , 1972, Cancer research.